Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999–2015
Author(s) -
Sang Taek Heo,
Alexander M. Tatara,
Cristina JiménezOrtigosa,
Ying Jiang,
Russell E. Lewis,
Jeffrey Tarrand,
Frank Tverdek,
Nathaniel D. Albert,
Paul E. Verweij,
Jacques F. Meis,
Antonios G. Mikos,
David S. Perlin,
Dimitrios P. Kontoyiannis
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix297
Subject(s) - aspergillus fumigatus , aspergillosis , posaconazole , voriconazole , azole , aspergillus , medicine , cancer , odds ratio , fluconazole , microbiology and biotechnology , gastroenterology , biology , immunology , antifungal
Azole-resistant aspergillosis in high-risk patients with hematological malignancy or hematopoietic stem cell transplantation (HSCT) is a cause of concern.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom